title: Oxidative capacity of skeletal muscle in heart failure patients versus sedentary or active control subjects.
abstract: OBJECTIVE
  We investigated the in situ properties of muscle mitochondria using the skinned fiber technique in patients with chronic heart failure (CHF) and sedentary (SED) and more active (ACT) controls to determine: 1) whether respiration of muscle tissue in the SED and ACT groups correlates with peak oxygen consumption (pVO(2)), 2) whether it is altered in CHF, and 3) whether this results from deconditioning or CHF-specific myopathy.
  
  
  BACKGROUND
  Skeletal muscle oxidative capacity is thought to partly determine the exercise capacity in humans and its decrease to participate in exercise limitation in CHF.
  
  
  METHODS
  M. Vastus lateralis biopsies were obtained from 11 SED group members, 10 ACT group members and 15 patients with CHF at the time of transplantation, saponine-skinned and placed in an oxygraphic chamber to measure basal and maximal adenosine diphosphate (ADP)-stimulated (V(max)) respiration rates and to assess mitochondrial regulation by ADP. All patients received angiotensin-converting enzyme (ACE) inhibitors.
  
  
  RESULTS
  The pVO(2) differed in the order CHF < SED < ACT. Compared with SED, muscle alterations in CHF appeared as decreased citrate synthase, creatine kinase and lactate dehydrogenase, whereas the myosin heavy chain profile remained unchanged. However, muscle oxidative capacity (V(max), CHF: 3.53 +/- 0.38; SED: 3.17 +/- 0.48; ACT: 7.47 +/- 0.73, micromol O(2).min(-1).g(-1)dw, p < 0.001 vs. CHF and SED) and regulation were identical in patients in the CHF and SED groups, differing in the ACT group only. In patients with CHF, the correlation between pVO(2) and muscle oxidative capacity observed in controls was displaced toward lower pVO(2) values.
  
  
  CONCLUSIONS
  In these patients, the disease-specific muscle metabolic impairments derive mostly from extramitochondrial mechanisms that disrupt the normal symmorphosis relations. The possible roles of ACE inhibitors and level of activity are discussed.
authors.affiliation: Département de Physiologie, Faculté de Médecine, Université Louis Pasteur, Strasbourg, France. Bertrand.Mettauer@physio-ulp.u-Strasbg.fr
authors.forename: B
authors.initials: B
authors.lastname: Mettauer
authors.forename: J
authors.initials: J
authors.lastname: Zoll
authors.forename: H
authors.initials: H
authors.lastname: Sanchez
authors.forename: E
authors.initials: E
authors.lastname: Lampert
authors.forename: F
authors.initials: F
authors.lastname: Ribera
authors.forename: V
authors.initials: V
authors.lastname: Veksler
authors.forename: X
authors.initials: X
authors.lastname: Bigard
authors.forename: P
authors.initials: P
authors.lastname: Mateo
authors.forename: E
authors.initials: E
authors.lastname: Epailly
authors.forename: J
authors.initials: J
authors.lastname: Lonsdorfer
authors.forename: R
authors.initials: R
authors.lastname: Ventura-Clapier
mesh_terms: D002950:Citrate (si)-Synthase / Q000378:metabolism; D003402:Creatine Kinase / Q000378:metabolism; D015444:Exercise / Q000502:physiology*; D005260:Female; D006333:Heart Failure / Q000378:metabolism*; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D008931:Mitochondria, Muscle / Q000378:metabolism*; D018482:Muscle, Skeletal / Q000378:metabolism*; D018995:Myosin Heavy Chains / Q000378:metabolism; D010101:Oxygen Consumption
chemical_list: D007770:L-Lactate Dehydrogenase; D002950:Citrate (si)-Synthase; D003402:Creatine Kinase; D018995:Myosin Heavy Chains